A Proof of Concept, Randomized, Double-blind, Placebo-controlled Trial of Orally Administered Belnacasan Tablets for the Treatment of Mild to Moderate COVID-19

Wortmann et al., NCT05164120, NCT05164120, Oct 2022

Source

PDF

All
Studies

Meta
Analysis

https://c19early.org/wortmann.html

RCT 40 outpatients in the USA, showing no significant difference in recovery with belnacasan treatment.

Standard of Care (SOC) for COVID-19 in the study country, the USA, is very poor with very low average efficacy for approved treatments1. Only expensive, high-profit treatments were approved. Low-cost treatments were excluded, reducing the probability of treatment—especially early—due to access and cost barriers, and eliminating complementary and synergistic benefits seen with many low-cost treatments.

Important missing comments or errors? Let us know.

recovery time, 33.8% higher, relative time 1.34, p = 0.29, treatment mean 20.6 (±18.1) n=14, control mean 15.4 (±7.8) n=17, time to sustained recovery or resolution of common COVID-19 symptoms.

recovery time, 43.2% higher, relative time 1.43, p = 0.05, treatment mean 27.2 (±14.3) n=17, control mean 19.0 (±8.9) n=17, time to WHO scale 0.

recovery time, 31.0% higher, relative time 1.31, p = 0.39, treatment mean 9.3 (±6.1) n=15, control mean 7.1 (±5.0) n=8, time to WHO scale 1.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

1. c19early.org, c19early.org/soc/usa.html.c19early.org/soc/usa.html.

Wortmann et al., 11 Oct 2022, Double Blind Randomized Controlled Trial, placebo-controlled, USA, preprint, 1 author, trial NCT05164120 (history). Contact: Alexander.Kroemer@gunet.georgetown.edu, Khalid.M.Khan@gunet.georgetown.edu.

This Paper Belnacasan All

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0